Market News

NASDAQ:KRYS News

3 stories
tradingview

Krystal Biotech files patent response citing single-patient KB801 corneal closure

Krystal Biotech disclosed a single-patient corneal epithelial defect closure in a patent office response for KB801.Key Highlights:Original SEC Filing: Krystal Biotech, Inc. [ KRYS ] - 8-K - Jul. 21, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informa…

TradingView en_IN
StocksUS